User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.

Primary tabs

download
  • Open access
  • PDF
  • 2.43 M
Dufrasne, François E. [UCL] Lombard, Catherine [UCL] Goubau, Patrick [UCL] Ruelle, Jean [UCL]

BST-2 or tetherin is a host cell restriction factor that prevents the budding of enveloped viruses at the cell surface, thus impairing the viral spread. Several countermeasures to evade this antiviral factor have been positively selected in retroviruses: the human immunodeficiency virus type 2 (HIV-2) relies on the envelope glycoprotein (Env) to overcome BST-2 restriction. The Env gp36 ectodomain seems involved in this anti-tetherin activity, however residues and regions interacting with BST-2 are not clearly defined. Among 32 HIV-2 ROD Env mutants tested, we demonstrated that the asparagine residue at position 659 located in the gp36 ectodomain is mandatory to exert the anti-tetherin function. Viral release assays in cell lines expressing BST-2 showed a loss of viral release ability for the HIV-2 N659D mutant virus compared to the HIV-2 wild type virus. In bst-2 inactivated H9 cells, those differences were lost. Subtilisin treatment of infected cells demonstrated that the N659D mutant was more tethered at the cell surface. Förster resonance energy transfer (FRET) experiments confirmed a direct molecular link between Env and BST-2 and highlighted an inability of the mutant to bind BST-2. We also tested a virus presenting a truncation of 109 amino acids at the C-terminal part of Env, a cytoplasmic tail partial deletion that is spontaneously selected in vitro. Interestingly, viral release assays and FRET experiments indicated that a full Env cytoplasmic tail was essential in BST-2 antagonism. In HIV-2 infected cells, an efficient Env-mediated antagonism of BST-2 is operated through an intermolecular link involving the asparagine 659 residue as well as the C-terminal part of the cytoplasmic tail.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2016
Language Anglais
Journal information "Viruses" - Vol. 8, no. 10, p. 285 [1-17] (2016)
Peer reviewed yes
Publisher MDPI AG ((Switzerland) Basel)
e-issn 1999-4915
Publication status Publié
Affiliations UCL - SSS/IREC/MBLG - Pôle de Microbiologie médicale
UCL - (SLuc) Service de microbiologie
UCL - SSS/IREC/PEDI - Pôle de Pédiatrie
Keywords BST-2 ; CRISPR/Cas9 knockout ; Env ; FRET ; HIV-2 ; Envelope glycoprotein ; Gp36 ; Restriction factors ; Tetherin ; Viral antagonist
Links
  1. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M., Santos-Ferreira M., Laurent A., Dauguet C, Katlama C, Rouzioux C, al. e., Isolation of a new human retrovirus from West African patients with AIDS, 10.1126/science.2425430
  2. Sharp P. M., Hahn B. H., Origins of HIV and the AIDS Pandemic, 10.1101/cshperspect.a006841
  3. Lemey P., Pybus O. G., Wang B., Saksena N. K., Salemi M., Vandamme A.-M., Tracing the origin and history of the HIV-2 epidemic, 10.1073/pnas.0936469100
  4. de Silva Thushan I., Cotten Matthew, Rowland-Jones Sarah L., HIV-2: the forgotten AIDS virus, 10.1016/j.tim.2008.09.003
  5. Peeters, AIDS Rev., 16, 23 (2014)
  6. Popper S. J., Sarr A. D., Gueye-Ndiaye A., Mboup S., Essex M. E., Kanki P. J., Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production In Vivo, 10.1128/jvi.74.3.1554-1557.2000
  7. Reeves Jacqueline D., Doms Robert W., Human immunodeficiency virus type 2, 10.1099/0022-1317-83-6-1253
  8. Damond F., Gueudin M., Pueyo S., Farfara I., Robertson D. L., Descamps D., Chene G., Matheron S., Campa P., Brun-Vezinet F., Simon F., Plasma RNA Viral Load in Human Immunodeficiency Virus Type 2 Subtype A and Subtype B Infections, 10.1128/jcm.40.10.3654-3659.2002
  9. Rowland-Jones Sarah L, Whittle Hilton C, Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?, 10.1038/ni0407-329
  10. Thiébaut Rodolphe, Matheron Sophie, Taieb Audrey, Brun-Vezinet Francoise, Chêne Geneviève, Autran Brigitte, Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort : , 10.1097/qad.0b013e328344892e
  11. Gottlieb Geoffrey S, Hawes Stephen E, Kiviat Nancy B, Sow Papa Salif, Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients : , 10.1097/qad.0b013e328303496d
  12. de Silva Thushan I., van Tienen Carla, Onyango Clayton, Jabang Abdoulie, Vincent Tim, Loeff Maarten F. Schim van der, Coutinho Roel A., Jaye Assan, Rowland-Jones Sarah, Whittle Hilton, Cotten Matthew, Hué Stéphane, Population dynamics of HIV-2 in rural West Africa : comparison with HIV-1 and ongoing transmission at the heart of the epidemic, 10.1097/qad.0b013e32835ab12c
  13. Sheehy Ann M., Gaddis Nathan C., Choi Jonathan D., Malim Michael H., Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein, 10.1038/nature00939
  14. Stremlau Matthew, Owens Christopher M., Perron Michel J., Kiessling Michael, Autissier Patrick, Sodroski Joseph, The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys, 10.1038/nature02343
  15. Neil Stuart J. D., Zang Trinity, Bieniasz Paul D., Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu, 10.1038/nature06553
  16. Van Damme Nanette, Goff Daniel, Katsura Chris, Jorgenson Rebecca L., Mitchell Richard, Johnson Marc C., Stephens Edward B., Guatelli John, The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein, 10.1016/j.chom.2008.03.001
  17. Perez-Caballero David, Zang Trinity, Ebrahimi Alaleh, McNatt Matthew W., Gregory Devon A., Johnson Marc C., Bieniasz Paul D., Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells, 10.1016/j.cell.2009.08.039
  18. Jouvenet N., Neil S. J. D., Zhadina M., Zang T., Kratovac Z., Lee Y., McNatt M., Hatziioannou T., Bieniasz P. D., Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin, 10.1128/jvi.02211-08
  19. Tokarev Andrey, Skasko Mark, Fitzpatrick Kathleen, Guatelli John, Antiviral Activity of the Interferon-Induced Cellular Protein BST-2/Tetherin, 10.1089/aid.2009.0253
  20. Evans David T., Serra-Moreno Ruth, Singh Rajendra K., Guatelli John C., BST-2/tetherin: a new component of the innate immune response to enveloped viruses, 10.1016/j.tim.2010.06.010
  21. Neil, Curr. Top. Microbiol. Immunol., 371, 67 (2013)
  22. Hinz Andreas, Miguet Nolwenn, Natrajan Ganesh, Usami Yoshiko, Yamanaka Hikaru, Renesto Patricia, Hartlieb Bettina, McCarthy Andrew A., Simorre Jean-Pierre, Göttlinger Heinrich, Weissenhorn Winfried, Structural Basis of HIV-1 Tethering to Membranes by the BST-2/Tetherin Ectodomain, 10.1016/j.chom.2010.03.005
  23. Rollason R., Korolchuk V., Hamilton C., Schu P., Banting G., Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif, 10.1242/jcs.003343
  24. Sauter Daniel, Counteraction of the multifunctional restriction factor tetherin, 10.3389/fmicb.2014.00163
  25. Hotter Dominik, Sauter Daniel, Kirchhoff Frank, Emerging Role of the Host Restriction Factor Tetherin in Viral Immune Sensing, 10.1016/j.jmb.2013.09.029
  26. Kupzig Sabine, Korolchuk Viktor, Rollason Ruth, Sugden Anna, Wilde Andrew, Banting George, Bst-2/HM1.24 Is a Raft-Associated Apical Membrane Protein with an Unusual Topology : A Raft Protein with an Unusual Topology, 10.1034/j.1600-0854.2003.00129.x
  27. Le Tortorec Anna, Willey Suzanne, Neil Stuart J. D., Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction, 10.3390/v3050520
  28. Billcliff P. G., Gorleku O. A., Chamberlain L. H., Banting G., The cytosolic N-terminus of CD317/tetherin is a membrane microdomain exclusion motif, 10.1242/bio.20135793
  29. Venkatesh Siddarth, Bieniasz Paul D., Mechanism of HIV-1 Virion Entrapment by Tetherin, 10.1371/journal.ppat.1003483
  30. Andrew Amy J., Kao Sandra, Strebel Klaus, C-terminal Hydrophobic Region in Human Bone Marrow Stromal Cell Antigen 2 (BST-2)/Tetherin Protein Functions as Second Transmembrane Motif, 10.1074/jbc.m111.287011
  31. Gupta Ravindra K., Hué Stéphane, Schaller Torsten, Verschoor Ernst, Pillay Deenan, Towers Greg J., Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion, 10.1371/journal.ppat.1000443
  32. McNatt Matthew W., Zang Trinity, Hatziioannou Theodora, Bartlett Mackenzie, Fofana Ismael Ben, Johnson Welkin E., Neil Stuart J. D., Bieniasz Paul D., Species-Specific Activity of HIV-1 Vpu and Positive Selection of Tetherin Transmembrane Domain Variants, 10.1371/journal.ppat.1000300
  33. Sauter Daniel, Specht Anke, Kirchhoff Frank, Tetherin: Holding On and Letting Go, 10.1016/j.cell.2010.04.022
  34. Heusinger Elena, Kluge Silvia F., Kirchhoff Frank, Sauter Daniel, Early Vertebrate Evolution of the Host Restriction Factor Tetherin, 10.1128/jvi.02149-15
  35. Strebel Klaus, HIV accessory proteins versus host restriction factors, 10.1016/j.coviro.2013.08.004
  36. Dubé Mathieu, Bhusan Roy Bibhuti, Guiot-Guillain Pierre, Binette Julie, Mercier Johanne, Chiasson Antoine, Cohen Éric A., Antagonism of Tetherin Restriction of HIV-1 Release by Vpu Involves Binding and Sequestration of the Restriction Factor in a Perinuclear Compartment, 10.1371/journal.ppat.1000856
  37. Goffinet Christine, Allespach Ina, Homann Stefanie, Tervo Hanna-Mari, Habermann Anja, Rupp Daniel, Oberbremer Lena, Kern Christian, Tibroni Nadine, Welsch Sonja, Krijnse-Locker Jacomine, Banting George, Kräusslich Hans-Georg, Fackler Oliver T., Keppler Oliver T., HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor, 10.1016/j.chom.2009.01.009
  38. Kobayashi T., Ode H., Yoshida T., Sato K., Gee P., Yamamoto S. P., Ebina H., Strebel K., Sato H., Koyanagi Y., Identification of Amino Acids in the Human Tetherin Transmembrane Domain Responsible for HIV-1 Vpu Interaction and Susceptibility, 10.1128/jvi.01668-10
  39. Pang Xiaojing, Hu Siqi, Li Jian, Xu Fengwen, Mei Shan, Zhou Jinming, Cen Shan, Jin Qi, Guo Fei, Identification of novel key amino acids at the interface of the transmembrane domains of human BST-2 and HIV-1 Vpu, 10.1186/1742-4690-10-84
  40. Vigan R., Neil S. J. D., Determinants of Tetherin Antagonism in the Transmembrane Domain of the Human Immunodeficiency Virus Type 1 Vpu Protein, 10.1128/jvi.01699-10
  41. McNatt Matthew W., Zang Trinity, Bieniasz Paul D., Vpu Binds Directly to Tetherin and Displaces It from Nascent Virions, 10.1371/journal.ppat.1003299
  42. Douglas J. L., Viswanathan K., McCarroll M. N., Gustin J. K., Fruh K., Moses A. V., Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a  TrCP-Dependent Mechanism, 10.1128/jvi.00242-09
  43. Arias Juan F., Iwabu Yukie, Tokunaga Kenzo, Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism, 10.3389/fmicb.2011.00250
  44. Hauser Heiko, Lopez Lisa A, Yang Su Jung, Oldenburg Jill E, Exline Colin M, Guatelli John C, Cannon Paula M, HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment, 10.1186/1742-4690-7-51
  45. Zhang Fengwen, Wilson Sam J., Landford Wilmina C., Virgen Beatriz, Gregory Devon, Johnson Marc C., Munch Jan, Kirchhoff Frank, Bieniasz Paul D., Hatziioannou Theodora, Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists, 10.1016/j.chom.2009.05.008
  46. Serra-Moreno Ruth, Zimmermann Kerstin, Stern Lawrence J., Evans David T., Tetherin/BST-2 Antagonism by Nef Depends on a Direct Physical Interaction between Nef and Tetherin, and on Clathrin-mediated Endocytosis, 10.1371/journal.ppat.1003487
  47. Jia Bin, Serra-Moreno Ruth, Neidermyer William, Rahmberg Andrew, Mackey John, Fofana Ismael Ben, Johnson Welkin E., Westmoreland Susan, Evans David T., Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2, 10.1371/journal.ppat.1000429
  48. Le Tortorec A., Neil S. J. D., Antagonism to and Intracellular Sequestration of Human Tetherin by the Human Immunodeficiency Virus Type 2 Envelope Glycoprotein, 10.1128/jvi.01515-09
  49. Bakouche Nordine, Vandenbroucke Anne-Thérèse, Goubau Patrick, Ruelle Jean, Study of the HIV-2 Env Cytoplasmic Tail Variability and Its Impact on Tat, Rev and Nef, 10.1371/journal.pone.0079129
  50. Exline Colin M, Yang Su Jung, Haworth Kevin G, Rengarajan Srinivas, Lopez Lisa A, Droniou Magali E, Seclen Eduardo, Cannon Paula M, Determinants in HIV-2 Env and tetherin required for functional interaction, 10.1186/s12977-015-0194-0
  51. Bour Stephan, Akari Hirofumi, Miyagi Eri, Strebel Klaus, Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release, 10.1016/s0042-6822(02)00128-9
  52. Bour, J. Virol., 73, 778 (1999)
  53. Ribeiro A. C., Maia e Silva A., Santa-Marta M., Pombo A., Moniz-Pereira J., Goncalves J., Barahona I., Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G, 10.1128/jvi.79.2.823-833.2005
  54. Bour, J. Virol., 70, 820 (1996)
  55. Serra-Moreno Ruth, Jia Bin, Breed Matthew, Alvarez Xavier, Evans David T., Compensatory Changes in the Cytoplasmic Tail of gp41 Confer Resistance to Tetherin/BST-2 in a Pathogenic Nef-Deleted SIV, 10.1016/j.chom.2010.12.005
  56. Serra-Moreno Ruth, The end of Nef's tether, 10.1016/j.tim.2014.10.008
  57. Postler T. S., Desrosiers R. C., The Tale of the Long Tail: the Cytoplasmic Domain of HIV-1 gp41, 10.1128/jvi.02053-12
  58. Matsuda Kenta, Chen Chia-Yen, Whitted Sonya, Chertova Elena, Roser David J., Wu Fan, Plishka Ronald J., Ourmanov Ilnour, Buckler-White Alicia, Lifson Jeffrey D., Strebel Klaus, Hirsch Vanessa M., Enhanced antagonism of BST-2 by a neurovirulent SIV envelope, 10.1172/jci83725
  59. Lam Amy J, St-Pierre François, Gong Yiyang, Marshall Jesse D, Cranfill Paula J, Baird Michelle A, McKeown Michael R, Wiedenmann Jörg, Davidson Michael W, Schnitzer Mark J, Tsien Roger Y, Lin Michael Z, Improving FRET dynamic range with bright green and red fluorescent proteins, 10.1038/nmeth.2171
  60. Heckl Dirk, Kowalczyk Monika S, Yudovich David, Belizaire Roger, Puram Rishi V, McConkey Marie E, Thielke Anne, Aster Jon C, Regev Aviv, Ebert Benjamin L, Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing, 10.1038/nbt.2951
  61. Ruelle Jean, Yfantis Vasilieios, Duquenne Armelle, Goubau Patrick, Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification, 10.7448/ias.17.4.19675
  62. Ruelle J, Quantitative real-time PCR on Lightcycler® for the detection of human immunodeficiency virus type 2 (HIV-2), 10.1016/j.jviromet.2003.12.006
  63. da Silva Eveline, Mulinge Martin, Bercoff Danielle, The frantic play of the concealed HIV envelope cytoplasmic tail, 10.1186/1742-4690-10-54
  64. Shrestha Dilip, Jenei Attila, Nagy Péter, Vereb György, Szöllősi János, Understanding FRET as a Research Tool for Cellular Studies, 10.3390/ijms16046718
  65. Banning Carina, Votteler Jörg, Hoffmann Dirk, Koppensteiner Herwig, Warmer Martin, Reimer Rudolph, Kirchhoff Frank, Schubert Ulrich, Hauber Joachim, Schindler Michael, A Flow Cytometry-Based FRET Assay to Identify and Analyse Protein-Protein Interactions in Living Cells, 10.1371/journal.pone.0009344
  66. Abada P., Noble B., Cannon P. M., Functional Domains within the Human Immunodeficiency Virus Type 2 Envelope Protein Required To Enhance Virus Production, 10.1128/jvi.79.6.3627-3638.2005
  67. Behrendt R., Fiebig U., Kurth R., Denner J., Induction of Antibodies Binding to the Membrane Proximal External Region of gp36 of HIV-2, 10.1159/000324483
  68. Denner Joachim, Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1 : A comparative study, 10.4161/hv.23221
  69. Munoz-Barroso, J. Virol., 73, 6089 (1999)
  70. Montero M., van Houten N. E., Wang X., Scott J. K., The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design, 10.1128/mmbr.00020-07
  71. Salzwedel, J. Virol., 73, 2469 (1999)
Bibliographic reference Dufrasne, François E. ; Lombard, Catherine ; Goubau, Patrick ; Ruelle, Jean. Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.. In: Viruses, Vol. 8, no. 10, p. 285 [1-17] (2016)
Permanent URL http://hdl.handle.net/2078.1/179169